Original article| Volume 153, ISSUE 1, P17-23, January 2009

Transcription factor decoys for activator protein-1 (AP-1) inhibit oxidative stress-induced proliferation and matrix metalloproteinases in rat cardiac fibroblasts

Published:December 08, 2008DOI:
      Activator protein-1 (AP-1), which is a transcription factor, is implicated in the transcriptional regulation of a wide range of genes that participate in cell proliferation and extracellular matrix production. This investigation was performed to test the hypothesis that transfection of cardiac fibroblasts (CFs) with sufficient amounts of decoy oligodeoxynucleotides (ODNs) containing the AP-1-binding site would result in binding to the transfactor AP-1, which would thereby prevent CF proliferation and matrix metalloproteinase (MMP) expression. CFs from Sprague-Dawley rat hearts were cultured and exposed to different concentrations of xanthine + xanthine oxidase (XXO) and AP-1 decoy ODNs. MMP expression was assayed after oxidative stress and transfection with AP-1 decoy ODNs by real-time quantitative polymerase chain reaction and Western blot. Cell growth was determined by the cell count. XXO significantly increased the DNA-binding activity of AP-1 in a dose-dependent manner. We found that transfection with AP-1 decoy ODNs strongly inhibited XXO-induced CF proliferation and MMP gene expression in vitro. Taken together, our data demonstrate that AP-1 is a key transcription factor that mediates CF proliferation and MMP synthesis under oxidative stress. Transfection with AP-1 decoy ODNs may be a novel strategy to inhibit CF proliferation and MMP synthesis.


      AP-1 (activator protein-1), CF (cardiac fibroblast), DMEM (Dulbecco's modified eagle's medium), DTT (dithiothreitol), EDTA (ethylenediaminetetraacetic acid), EMSA (electrophoretic mobility shift assay), ERK (extracellular signal-regulated kinase), FBS (fetal bovine serum), HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), IgG (immunoglobulin G), JNK (c-Jun N-terminal kinase), MAPK (mitogen-activated protein kinase), M-decoy ODN (mutated AP-1 decoy ODN), MI (myocardial infarction), MMP (matrix metalloproteinase), mRNA (messenger RNA), ODN (oligodeoxynucleotide), PCR (polymerase chain reaction), PMSF (phenylmethylsulphonyl fluoride), PS (penicillin-streptomycin), XXO (xanthine + xanthine oxidase)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Siwik D.A.
        • Pagano P.J.
        • Colucci W.S.
        Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts.
        Am J Physiol Cell Physiol. 2001; 280: C53-C60
        • Fishbein M.C.
        • Maclean D.
        • Maroko P.R.
        Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution.
        Am J Pathol. 1978; 90: 57-70
        • Byun J.
        • Huh J.E.
        • Park S.J.
        • et al.
        Myocardial injury-induced fibroblast proliferation facilitates retroviral-mediated gene transfer to the rat heart in vivo.
        J Gene Med. 2000; 2: 2-10
        • Sutton M.G.
        • Sharpe N.
        Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.
        Circulation. 2000; 101: 2981-2988
        • Weber K.T.
        Fibrosis and hypertensive heart disease.
        Curr Opin Cardiol. 2000; 15: 264-272
        • Ahmed M.S.
        • Oie E.
        • Vinge L.E.
        • et al.
        Connective tissue growth factor–a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats.
        J Mol Cell Cardiol. 2004; 36: 393-404
        • Peterson J.T.
        • Li H.
        • Dillon L.
        • Bryant J.W.
        Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
        Cardiovasc Res. 2000; 46: 307-315
        • Bradham W.S.
        • Moe G.
        • Wendt K.A.
        • et al.
        TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.
        Am J Physiol Heart Circ Physiol. 2002; 282: H1288-H1295
        • Siwik D.A.
        • Chang D.L.
        • Colucci W.S.
        Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.
        Circ Res. 2000; 86: 1259-1265
        • Cheng T.H.
        • Cheng P.Y.
        • Shih N.L.
        • Chen I.B.
        • Wang D.L.
        • Chen J.J.
        Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts.
        J Am Coll Cardiol. 2003; 42: 1845-1854
        • Sadoshima J.
        • Izumo S.
        Molecular characterization of angiotensin II–induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
        Circ Res. 1993; 73: 413-423
        • Tyagi S.C.
        • Kumar S.
        • Borders S.
        Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells.
        J Cell Biochem. 1996; 61: 139-151
        • Giordano F.J.
        Oxygen, oxidative stress, hypoxia, and heart failure.
        J Clin Invest. 2005; 115: 500-508
        • Shao Z.
        • Bhattacharya K.
        • Hsich E.
        • et al.
        c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo.
        Circ Res. 2006; 98: 111-118
        • Cook S.A.
        • Sugden P.H.
        • Clerk A.
        Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease.
        J Mol Cell Cardiol. 1999; 31: 1429-1434
        • Zhang X.
        • Azhar G.
        • Nagano K.
        • Wei J.Y.
        Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts.
        J Am Coll Cardiol. 2001; 38: 2055-2062
        • Karin M.
        The regulation of AP-1 activity by mitogen-activated protein kinases.
        J Biol Chem. 1995; 270: 16483-16486
        • Deschamps A.M.
        • Spinale F.G.
        Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
        Cardiovasc Res. 2006; 69: 666-676
        • Ahn J.D.
        • Morishita R.
        • Kaneda Y.
        • et al.
        Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo.
        Circ Res. 2002; 90: 1325-1332
        • Villarreal F.J.
        • Kim N.N.
        • Ungab G.D.
        • Printz M.P.
        • Dillmann W.H.
        Identification of functional angiotensin II receptors on rat cardiac fibroblasts.
        Circulation. 1993; 88: 2849-2861
        • Morishita R.
        • Gibbons G.H.
        • Horiuchi M.
        • Kaneda Y.
        • Ogihara T.
        • Dzau V.J.
        Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.
        Biochem Biophys Res Commun. 1998; 243: 361-367
        • Ahn J.D.
        • Morishita R.
        • Kaneda Y.
        • et al.
        Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells.
        Diabetologia. 2001; 44: 713-720
        • Ahn J.D.
        • Morishita R.
        • Kaneda Y.
        • et al.
        Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.
        Gene Ther. 2004; 11: 916-923
        • Burdon R.H.
        Superoxide and hydrogen peroxide in relation to mammalian cell proliferation.
        Free Radic Biol Med. 1995; 18: 775-794
        • Sauer H.
        • Wartenberg M.
        • Hescheler J.
        Reactive oxygen species as intracellular messengers during cell growth and differentiation.
        Cell Physiol Biochem. 2001; 11: 173-186
        • Cohn J.N.
        • Colucci W.
        Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology.
        Am J Cardiol. 2006; 97: 4F-12F
        • Keith M.
        • Geranmayegan A.
        • Sole M.J.
        • et al.
        Increased oxidative stress in patients with congestive heart failure.
        J Am Coll Cardiol. 1998; 31: 1352-1356
        • Li P.F.
        • Dietz R.
        • von Harsdorf R.
        Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts.
        FEBS Lett. 1999; 448: 206-210
        • Spinale F.G.
        Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
        Physiol Rev. 2007; 87: 1285-1342
        • Mukherjee R.
        • Mingoia J.T.
        • Bruce J.A.
        • et al.
        Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
        Am J Physiol Heart Circ Physiol. 2006; 291: H2216-H2228
        • Sun Y.
        • Zhang J.Q.
        • Zhang J.
        • Lamparter S.
        Cardiac remodeling by fibrous tissue after infarction in rats.
        J Lab Clin Med. 2000; 135: 316-323
        • Kelly D.
        • Cockerill G.
        • Ng L.L.
        • et al.
        Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.
        Eur Heart J. 2007; 28: 711-718
        • Yarbrough W.M.
        • Mukherjee R.
        • Escobar G.P.
        • et al.
        Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
        Circulation. 2003; 108: 1753-1759